Fabrication of chitosan-bis (4-formyl-2 methoxy phenyl carbonate) Schiff base nanoparticles and evaluation of their antioxidant and anticancer properties
- PMID: 31115838
- DOI: 10.1007/s11033-019-04887-4
Fabrication of chitosan-bis (4-formyl-2 methoxy phenyl carbonate) Schiff base nanoparticles and evaluation of their antioxidant and anticancer properties
Abstract
The present study details on the mechanism of synthesis of bis (4-formyl-2 methoxy phenyl carbonate), using two green reagents dimethyl carbonate and vanillin for application as therapeutic agent. The synthesized FMPC was identified from the 13C nuclear magnetic resonance spectra. The novel modified Schiff base nanoparticles resulted from the crosslinking of FMPC with chitosan were confirmed by cross-polarization magic angle spinning carbon-13 nuclear magnetic resonance spectroscopy. The incorporation of the FMPC was identified from the amorphous X-ray diffraction patterns of C-FMPC-Nps. The thermal stability of the formed nanoparticles was predicted using thermogravimetric analysis. The morphology of the nanoparticles as observed from HRTEM was found to be smooth and spherical in nature. Both FMPC and C-FMPC-Nps showed significant radical scavenging potential and anticancer property. The carbonate ester backbone and the moiety present in chitosan-FMPC-nanoparticles, underwent hydrolysis at the targeted cancer causing microenvironment to release vanillin and chitosan and enhance the anticancer activity. Both FMPC and C-FMPC-Nps exhibits a dose dependent cytotoxicity towards the different cell lines and it was tested with a commercial drug for application studies. Effective synthesis of FMPC, successful incorporation onto chitosan nanoparticles for the formation of C-FMPC-Nps. The formed Schiff base compound proves to have enhanced antioxidant and anticancer efficacy.
Keywords: Anticancer; Chitosan; DMC; FMPC; Oxaliplatin; Vanillin.
Similar articles
-
Curcumin drug delivery by vanillin-chitosan coated with calcium ferrite hybrid nanoparticles as carrier.Eur J Pharm Sci. 2018 Apr 30;116:48-60. doi: 10.1016/j.ejps.2018.01.023. Epub 2018 Feb 3. Eur J Pharm Sci. 2018. PMID: 29355595
-
One pot synthesis of new cross-linked chitosan-Schiff' base: Characterization, and anti-proliferative activities.Int J Biol Macromol. 2021 Aug 1;184:558-565. doi: 10.1016/j.ijbiomac.2021.06.137. Epub 2021 Jun 24. Int J Biol Macromol. 2021. PMID: 34174299
-
Enhanced tumor delivery and antitumor response of doxorubicin-loaded albumin nanoparticles formulated based on a Schiff base.Int J Nanomedicine. 2016 Aug 12;11:3875-90. doi: 10.2147/IJN.S108689. eCollection 2016. Int J Nanomedicine. 2016. PMID: 27574421 Free PMC article.
-
Nano-Chitosan Particles in Anticancer Drug Delivery: An Up-to-Date Review.Mini Rev Med Chem. 2017;17(15):1457-1487. doi: 10.2174/1389557517666170228105731. Mini Rev Med Chem. 2017. PMID: 28245780 Review.
-
Anticancer Activity of Chitosan, Chitosan Derivatives, and Their Mechanism of Action.Int J Biomater. 2018 Dec 30;2018:2952085. doi: 10.1155/2018/2952085. eCollection 2018. Int J Biomater. 2018. PMID: 30693034 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous